GR3031817T3 - DNA sequences encoding modified retroviral gag polypeptides and vaccines containing them or aggregates thereof. - Google Patents

DNA sequences encoding modified retroviral gag polypeptides and vaccines containing them or aggregates thereof.

Info

Publication number
GR3031817T3
GR3031817T3 GR990402910T GR990402910T GR3031817T3 GR 3031817 T3 GR3031817 T3 GR 3031817T3 GR 990402910 T GR990402910 T GR 990402910T GR 990402910 T GR990402910 T GR 990402910T GR 3031817 T3 GR3031817 T3 GR 3031817T3
Authority
GR
Greece
Prior art keywords
gag
vaccinia
addition
particles
expression
Prior art date
Application number
GR990402910T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8203785&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GR3031817(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GR3031817T3 publication Critical patent/GR3031817T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GR990402910T 1990-03-21 1999-11-10 DNA sequences encoding modified retroviral gag polypeptides and vaccines containing them or aggregates thereof. GR3031817T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90105319 1990-03-21
EP91104432A EP0449116B2 (en) 1990-03-21 1991-03-21 DNA sequences encoding modified retroviral gag polypeptides and vaccines containing them or aggregates thereof

Publications (1)

Publication Number Publication Date
GR3031817T3 true GR3031817T3 (en) 2000-02-29

Family

ID=8203785

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990402910T GR3031817T3 (en) 1990-03-21 1999-11-10 DNA sequences encoding modified retroviral gag polypeptides and vaccines containing them or aggregates thereof.

Country Status (5)

Country Link
EP (1) EP0449116B2 (el)
AT (1) ATE183235T1 (el)
DE (1) DE69131513T3 (el)
ES (1) ES2140380T5 (el)
GR (1) GR3031817T3 (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773211A (en) * 1991-07-10 1998-06-30 Abbott Laboratories Differentiation of HTLV-I and HTLV-II using synthetic peptides
GB9208218D0 (en) * 1992-04-14 1992-05-27 British Bio Technology Hybrid particles
EP0565794A1 (en) * 1992-04-14 1993-10-20 British Biotech Pharmaceuticals Limited Induction of CTL responses
ATE199394T1 (de) * 1992-06-04 2001-03-15 Univ Osaka Res Found Gag-env fusion-antigen aus hiv
AU6829494A (en) * 1993-08-02 1995-02-28 Chiron Corporation Recombinant constructs using replacement sequences in hypervariable regions
ATE288488T1 (de) * 1997-03-11 2005-02-15 Mayo Foundation Zusammensetzungen und verfahren zur eliminierung unerwünschter zellen
ES2299276T3 (es) 1998-12-31 2008-05-16 Novartis Vaccines And Diagnostics, Inc. Polipeptidos env del vih modificados.
US7935805B1 (en) 1998-12-31 2011-05-03 Novartis Vaccines & Diagnostics, Inc Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
JP2003523721A (ja) 1998-12-31 2003-08-12 カイロン コーポレイション 抗原性ｈｉｖｃ型ポリペプチドをコードするポリヌクレオチド、ポリペプチド、およびそれらの使用
CA2360347C (en) 1998-12-31 2013-05-07 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
CA2419822C (en) * 2000-08-14 2011-02-08 Gary J. Nabel Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
EP2280074A3 (en) 2001-07-05 2011-06-22 Novartis Vaccines and Diagnostics, Inc. Polynucleotides encoding antigenic HIV type B and/or type C polypeptides, polypeptides and uses thereof
US7211659B2 (en) 2001-07-05 2007-05-01 Chiron Corporation Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
EP1427806A4 (en) 2001-08-31 2006-04-26 Chiron Corp ANTIGENIC HIV-TYPE B POLYPEPTIDE-CODING POLYNUCLEOTIDES, POLYPEPTIDES, AND USES THEREOF
US6835568B2 (en) 2001-10-30 2004-12-28 Virxsys Corporation Regulated nucleic acid expression system
EP1814583A2 (en) 2004-11-01 2007-08-08 Novartis Vaccines and Diagnostics, Inc. Combination approaches for generating immune responses
US8620059B2 (en) 2007-12-13 2013-12-31 Fpinnovations Characterizing wood furnish by edge pixelated imaging
US20140004146A1 (en) * 2011-03-17 2014-01-02 Institut Pasteur Of Shanghai, Chinese Academy Of Sciences Method for producing virus-like particle by using drosophila cell and applications thereof
RU2609769C2 (ru) 2011-04-06 2017-02-02 Биоваксим Лимитед Фармацевтическая композиция для профилактики и(или) лечения заболеваний вич у людей
WO2015193143A1 (en) 2014-06-18 2015-12-23 Morphosys Ag Fusion proteins and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
EP0343132B1 (en) * 1988-05-06 1994-08-17 Ferropas Ag Methods and systems for producing HIV antigens

Also Published As

Publication number Publication date
DE69131513T3 (de) 2005-05-25
ES2140380T5 (es) 2005-03-16
ATE183235T1 (de) 1999-08-15
DE69131513D1 (de) 1999-09-16
EP0449116B2 (en) 2004-08-25
ES2140380T3 (es) 2000-03-01
DE69131513T2 (de) 2000-05-04
EP0449116A1 (en) 1991-10-02
EP0449116B1 (en) 1999-08-11

Similar Documents

Publication Publication Date Title
GR3031817T3 (en) DNA sequences encoding modified retroviral gag polypeptides and vaccines containing them or aggregates thereof.
US5580773A (en) Chimeric immunogenic gag-V3 virus-like particles of the human immunodeficiency virus (HIV)
Lipka et al. Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes
EP0265785A2 (en) Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells
US5550052A (en) Hybrid cell line formed between T4 lymphocytes and tumoral lymphoid type cells
Strand et al. Structural proteins of mammalian oncogenic RNA viruses: immunological characterization of the p15 polypeptide of Rauscher murine virus
Wagner et al. Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles
JP2001527029A5 (el)
WO1992016556A1 (en) Derivatives opf gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant
KR100482616B1 (ko) 다수-서브타입fiv백신
ATE297984T1 (de) Mit hiv-2 infizierte menschliche t-zelllinie die funktionell intaktes hiv-2 gp160 sekretiert
US5443828A (en) Chimeric HIV-2 gag particles
Laurent et al. Cell surface expression of several species of human immunodeficiency virus type 1 major core protein
DE3879881D1 (de) Rekombinante hiv-2 polypeptide.
AU654970B2 (en) Derivatives of gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant
DE69231705D1 (de) Gag-Env Fusion-Antigen aus HIV
Marin et al. Chimeric synthetic peptides containing two immunodominant epitopes from the envelope gp46 and the transmembrane gp21 glycoproteins of HTLV-I virus
WO1988008449A1 (en) Hiv related human retrovirus strain with cloned nucleotide sequence and applications thereof
Edouard et al. Characterization of monoclonal antibodies directed against the gp46 of human T-cell leukemia virus type I.
JPS63254983A (ja) エイズの病原であるウイルスのｐ２５蛋白質をコードするウイルスベクター及び組換ＤＮＡ、感染された細胞培養物、得られる蛋白質、ワクチン及び得られる抗体
CA2084136A1 (en) Design, construction and expression of chimeric proteins for development of vaccines and diagnostic reagents
JPH01148183A (ja) 組み換えワクチニアウイルス